1 – 50 of 53
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines : a clinical implementation study
2024) In Breast Cancer Research and Treatment(
- Contribution to journal › Article
-
Mark
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers
(
- Contribution to journal › Article
- 2022
-
Mark
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants : Application of a points-based ACMG/AMP approach
(
- Contribution to journal › Article
- 2021
-
Mark
Genetic testing in women with early-onset breast cancer : a Traceback pilot study
(
- Contribution to journal › Article
- 2019
-
Mark
High patient satisfaction with a simplified BRCA1/2 testing procedure : long-term results of a prospective study
(
- Contribution to journal › Article
-
Mark
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer—an European consensus statement and expert recommendations
(
- Contribution to journal › Article
-
Mark
Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
(
- Contribution to journal › Article
-
Mark
Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
(
- Contribution to journal › Article
- 2018
-
Mark
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
(
- Contribution to journal › Article
-
Mark
Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study
(
- Contribution to journal › Article
-
Mark
Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study : experiences from re-contacting mutation carriers and relatives
(
- Contribution to journal › Article
- 2017
-
Mark
Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women
(
- Contribution to journal › Article
- 2015
-
Mark
Mutational analysis of BRCA1/2 in a group of 134 consecutive ovarian cancer patients. Novel and recurrent BRCA1/2 alterations detected by next generation sequencing
(
- Contribution to journal › Article
-
Mark
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers
(
- Contribution to journal › Article
- 2014
-
Mark
Insights into breast cancer: New familial patterns and identification of a potential predictive marker
(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Genetic factors in childhood cancer. Associations between tumors in childhood and adulthood, and prevalence of germline TP53 mutations
(
- Thesis › Doctoral thesis (compilation)
- 2011
-
Mark
High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer
(
- Contribution to journal › Article
-
Mark
Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
(
- Contribution to journal › Article
-
Mark
A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing
(
- Contribution to journal › Article
-
Mark
Exploring the link between MORF4L1 and risk of breast cancer
(
- Contribution to journal › Article
-
Mark
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(
- Contribution to journal › Article
-
Mark
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer : Preliminary analysis of the results of the IMPACT study
(
- Contribution to journal › Article
- 2010
-
Mark
Genetic polymorphisms, IGF-1, and oral contraceptive use in women from high-risk breast cancer families
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study
(
- Contribution to journal › Article
-
Mark
Impact of Lifestyle, Hormones, and Genes on Breast Cancer
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study
(
- Contribution to journal › Article
-
Mark
Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study
(
- Contribution to journal › Article
- 2009
-
Mark
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)
(
- Contribution to journal › Article
- 2008
-
Mark
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
(
- Contribution to journal › Article
- 2007
-
Mark
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
(
- Contribution to journal › Article
- 2006
-
Mark
Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors
(
- Contribution to journal › Article
-
Mark
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update
(
- Contribution to journal › Article
- 2005
-
Mark
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
(
- Contribution to journal › Article
-
Mark
Functional and Molecular Characterization of BRCA1 and BRCA2 Associated Breast Cancer
2005)(
- Thesis › Doctoral thesis (compilation)
- 2004
-
Mark
BRCA2 mutations in 154 Finnish male breast cancer patients
(
- Contribution to journal › Article
-
Mark
Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables
(
- Contribution to journal › Article
-
Mark
Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation
(
- Contribution to journal › Article
-
Mark
BRCA1 och BRCA2 har nått kliniken. Tioårigt fynd av genmutation ger nu möjlighet förebygga ärftlig bröstcan
(
- Contribution to journal › Article
- 2003
-
Mark
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status
(
- Contribution to journal › Scientific review
-
Mark
Clinical Aspects of Hereditary Breast Cancer
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Gene Expression Profiling of Hereditary Breast Cancer
2002)(
- Thesis › Doctoral thesis (compilation)
- 2001
-
Mark
Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families
(
- Contribution to journal › Article
-
Mark
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa
(
- Contribution to journal › Article
-
Mark
The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series
(
- Contribution to journal › Article
-
Mark
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
(
- Contribution to journal › Article
-
Mark
Molecular and pathological characterization of inherited breast cancer.
(
- Contribution to journal › Article
-
Mark
Molecular Genetic Alterations In Endometrial And Ovarian Cancers
2001)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article